A trial to study the EGFR mutation type and efficacy of afatinib in patients who previously treated with EGFR-TKI
Latest Information Update: 28 Jul 2016
At a glance
- Drugs Afatinib (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacodynamics; Therapeutic Use
- 28 Jul 2016 New trial record
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology